Breaking News
January 20, 2018 - Evidensia Sweden orders Sectra cloud-based PACS for reviewing all medical images
January 20, 2018 - Researchers test new anti-malaria medication
January 20, 2018 - Small Joint Surgeries Drop among RA Patients
January 20, 2018 - Young people with shared residency have fewer mental problems
January 20, 2018 - Childhood physical activity may have far-reaching implications
January 20, 2018 - Overweight female kidney donors of childbearing age may have greater preeclampsia risk
January 20, 2018 - MSU scientists seek to identify brain mechanisms related to psychosis
January 20, 2018 - Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer
January 20, 2018 - Endoscopes Over Microscopes in Retinal Surgery: Ophthalmology Times
January 20, 2018 - Technology not taking over children’s lives despite screen-time increase
January 20, 2018 - Study finds extensive contamination around lead battery recycling plants in 7 African countries
January 20, 2018 - Flu may pass to others through exhaled breath, study shows
January 20, 2018 - Neuronal loss very limited in Alzheimer’s disease, new study shows
January 20, 2018 - Novel robot can aid treatment of rare birth defect
January 19, 2018 - TherapeuticsMD Announces Submission of New Drug Application for TX-001HR
January 19, 2018 - Fighting Infant Mortality | Medpage Today
January 19, 2018 - Researchers offer new evidence on four-year-old children’s knowledge about ecology
January 19, 2018 - Analysis finds overlooked crucial factor in determining prognosis for DIPGs
January 19, 2018 - Review explores consequences of genetic testing and cancer risk-reducing surgery
January 19, 2018 - Morning Break: HHS Div. of Religious Freedom; Trump’s Heart Health; Minister of Loneliness
January 19, 2018 - Parkinson’s disease ‘jerking’ side effect detected by algorithm
January 19, 2018 - New analysis finds dramatic increases in maternal mortality rates
January 19, 2018 - Study reveals key mechanism of how cancer metastasis happens
January 19, 2018 - Weight-Loss Surgery’s Benefits Wane Over Time for Diabetics
January 19, 2018 - Cath Lab Recap: Sapien 3 Delivery System Recall; Transatlantic PCI Smackdown
January 19, 2018 - Parkinson’s treatment could be more effective, student finds
January 19, 2018 - New vaccine approach offers effective protection against tuberculosis
January 19, 2018 - Home care agencies often wrongly deny Medicare help to the chronically ill
January 19, 2018 - One hundred percent fruit juice does not alter blood sugar levels
January 19, 2018 - Prebiotics could enhance learning and memory skills in infants
January 19, 2018 - CMS May Cover MRI With Cardiac Devices Across the Board
January 19, 2018 - As income rises, women get slimmer—but not men
January 19, 2018 - Researchers develop adhesive materials to prevent bracket stains on teeth
January 19, 2018 - Flu can be spread without coughs and sneezes
January 19, 2018 - AMSBIO’s new recombinant protein shows great promise for organoid culture
January 19, 2018 - AbbVie’s Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis
January 19, 2018 - ASH: Pomalidomide Dose Escalation Improves Response
January 19, 2018 - Is your child’s school an obesity risk?
January 19, 2018 - Scientists describe groundbreaking training effect on the innate immune system
January 19, 2018 - MAST announces new AmpC, ESBL & Carbapenemase Detection Set
January 19, 2018 - Signaling molecules likely involved in concussions, rodent studies show
January 19, 2018 - Mast introduces Carba plus for CPE and OXA-48 confirmation
January 19, 2018 - Paleolithic diet helps overweight women maintain weight loss
January 19, 2018 - Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Relapsed/Refractory AML and an IDH1 Mutation
January 19, 2018 - This Flu Season, Don’t Forget About Tamiflu
January 19, 2018 - Amsterdam wins battle to host EU medicines agency after Brexit
January 19, 2018 - Study suggests movement as accurate method to diagnose neurodevelopmental disorders
January 19, 2018 - Maximize resolution in deep imaging for neuroscience research with Olympus TruResolution objectives
January 19, 2018 - Bilingualism may benefit children with ASD
January 19, 2018 - FDA Alert: Levofloxacin in 5 Percent Dextrose 250mg/50mL by AuroMedics: Recall
January 19, 2018 - USPSTF Not Backing Ankle-Brachial Index, CRP, or Coronary Calcium
January 19, 2018 - Higher omega-3 fatty acid intake tied to lower glaucoma risk
January 19, 2018 - Findings reveal conventional cancer therapy as double-edged sword
January 19, 2018 - Health Highlights: Jan. 16, 2018
January 19, 2018 - Morning Break: Anti-Emetic Warning; Uninsured Rate Jumps; Flu Worsens Saline Shortage
January 19, 2018 - Increased use of ambulatory surgery centers for cataract surgery
January 19, 2018 - Not-for-profit hospitals coming up with their own generic medicines to combat shortages
January 19, 2018 - $500 cancer detection blood tests may soon become reality
January 19, 2018 - Chronic traumatic encephalopathy may start early even without signs of concussions
January 19, 2018 - Warm-up program for children cuts soccer injuries by 50%
January 19, 2018 - ‘You’re Old and You Need Tests’: What We Heard This Week
January 19, 2018 - Egg-preserving hysterectomy raises heart risks later: study
January 19, 2018 - GA-map Dysbiosis Test identifies IBS patients who respond to FODMAP diet, study shows
January 19, 2018 - Study explores mortality and health-related habits in former elite athletes and their brothers
January 19, 2018 - New biodegradable sensors could assist doctors
January 19, 2018 - Modular gene enhancers may be suitable target in treatment of blood cancer
January 18, 2018 - New precision medicine trial for metastatic pancreatic cancer
January 18, 2018 - Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
January 18, 2018 - Pre-Existing Patient-Valve Mismatch Trips Up ViV Implant
January 18, 2018 - Adolescents: health risks and solutions
January 18, 2018 - US woman delivers baby from embryo frozen for 24 years
January 18, 2018 - Study identifies new target for treatment of depression
January 18, 2018 - LJI study reveals key player that promotes skin inflammation in atopic dermatitis
January 18, 2018 - Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations
January 18, 2018 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
January 18, 2018 - Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
January 18, 2018 - Researchers identify a new chemical pathway that helps the brain detect sweet, savory and bitter flavors
January 18, 2018 - IBV develops platform that helps companies to diagnose wellbeing of their workforce
January 18, 2018 - Study to test new precision medicine approach for metastatic pancreatic cancer
January 18, 2018 - World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
Financial savings lower than anticipated for generic oral chemotherapy

Financial savings lower than anticipated for generic oral chemotherapy

image_pdfDownload PDFimage_print

A find out about by means of researchers on the College of North Carolina Eshelman College of Pharmacy and Lineberger Complete Most cancers Heart made up our minds the associated fee financial savings for a generic model of an orally administered most cancers remedy have been lower than anticipated—a discovering that questions the affect generic medicine may have on controlling well being care prices.

The researchers record within the JAMA Inner Medication that the associated fee for one fill of the generic type of the chemotherapy remedy capecitabine used to be $2,328 remaining yr. That value used to be 36 % not up to the projected branded drug value in 2016—a financial savings the researchers deemed modest in comparison to discounts observed for different generic medicine.

“For this oral most cancers remedy, we do not see the extent of value relief that we might be expecting for generic drug access,” mentioned the find out about’s senior creator Stacie Dusetzina, PhD, a UNC Lineberger member and assistant professor within the UNC Eshelman College of Pharmacy.

Dusetzina mentioned pageant from generic medicine has been a very powerful instrument for curtailing clinical prices and increasing remedy get right of entry to. On the identical time, corporations would possibly use generic value discounts as a rationale for environment upper costs for brand-name medicine, with the justification that costs can be considerably decrease after generics input the marketplace.

Capecitabine used to be one of the most first high-priced, orally administered most cancers remedies to lose patent coverage in the USA, the researchers record. They discovered that will increase in the cost of the brand-name drug, and a smaller-than-expected relief in the cost of the generic variations of the remedy, reduced the affect of generic pageant on costs 3 years after the brand-name drug got here off patent.

“The usage of capecitabine as a case find out about for the possible impact of generic pageant for orally-administered anti-cancer remedies, we discovered that discounts within the listing value have been extra modest than the ones noticed for different medicine with the similar collection of generic marketplace competition,” mentioned the find out about’s first creator Ashley Cole, MPH, a doctoral pupil and graduate analysis assistant within the UNC Eshelman College of Pharmacy.

The researchers used industrial insurance coverage claims information to estimate prescription costs for branded and generic capecitabine between 2002 and 2016. Capecitabine misplaced patent coverage in 2013, and in step with the researchers’ information, the primary fill for the generic selection used to be in March of 2014. The cost of a typical one-month provide of generic capecitabine averaged $2,598 in 2014, best 17 % under the projected branded drug value. By means of 2016, the typical generic value dropped to $2,328, which used to be 36 % under the projected branded drug value. Different research have discovered better financial savings for generic access, even in settings with a identical collection of competition.

In addition they made up our minds that brand-name drug costs larger over the years, and generic costs adopted go well with. In 2016, the cost of the generic capecitabine used to be very similar to the listing value of the brand-name drug in 2010, and it used to be 70 % upper than the brand-name drug’s listing value in 2002.

“The cost of capecitabine has greater than doubled since 2002, so even after generic access, the fee paid by means of well being plans continues to be upper than the branded drug’s authentic listing value after you alter for inflation,” Dusetzina mentioned. “If costs after generic access are in the end upper than authentic listing costs, then it’s not transparent that sufferers could have more uncomplicated get right of entry to to remedy following generic access.”

On this find out about of commercially insured sufferers, maximum sufferers had decrease out-of-pocket prices after generic access. On the other hand, about 10 % of folks paid greater than $100 for one fill of the drugs.

“As we see extra sufferers enrolled in excessive deductible well being plans, paying deductibles or co-insurance for his or her medicine, this loss of value relief would possibly without delay affect sufferers,” Dusetzina mentioned.

The findings will have coverage implications. Encouraging tough generic pageant may assist keep an eye on well being care prices, Dusetzina mentioned, because the collection of producers providing generic merchandise has been discovered to be similar to worth discounts.

“There may be an ongoing nationwide dialog round prescription drug costs, specifically forte medicine, like the ones utilized in oncology,” Cole mentioned. “Some have prompt that generic price cutting war can be a market-based option to this drawback. Our find out about supplies early proof that generic pageant by myself is probably not sufficient to rein within the excessive costs for orally administered most cancers remedies.”


Discover additional:
FDA takes steps to spice up generic pageant, prohibit costs

Magazine reference:
JAMA Inner Medication

Equipped by means of:
UNC Lineberger Complete Most cancers Heart

Tagged with:

About author

Related Articles